Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy | |
Liu, Rujiao; Zhao, Xiaoying; Liu, Xin; Chen, Zhiyu; Qiu, Lixin; Geng, Ruixuan; Guo, Weijian; He, Guang; Yin, Jiliang; Li, Jin | |
刊名 | TUMOR BIOLOGY |
2016 | |
卷号 | 37期号:2 |
关键词 | Gastric cancer EOF5 chemotherapy SNP polymorphism Overall survival Progression-free survival |
ISSN号 | 1010-4283 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4288138 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Liu, Rujiao,Zhao, Xiaoying,Liu, Xin,et al. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy[J]. TUMOR BIOLOGY,2016,37(2). |
APA | Liu, Rujiao.,Zhao, Xiaoying.,Liu, Xin.,Chen, Zhiyu.,Qiu, Lixin.,...&Zhu, Xiaodong.(2016).Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.TUMOR BIOLOGY,37(2). |
MLA | Liu, Rujiao,et al."Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy".TUMOR BIOLOGY 37.2(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论